Study Title
LCCC 1917: Dose Escalation of Low and Intermediate Risk Localized Prostate Cancer Using 68Ga-HBED-CC PSMA-PET/MRI and Stereotactic Body Radiotherapy
Study Details
Description:
The goal of this study is to determine the safety of using PSMA-PET/mpMRI to define radiotherapy targets, while meeting all current planning criteria. This study also intends to determine the feasibility of performing stereotactic body radiation therapy with simultaneous integrated boost on the dominant intra-prostatic lesions while meeting all current planning criteria.
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Contacts:
Panayiotis Mavroidis, PhDpanayiotis_mavroidis@med.unc.edu
984-974-8438
Sarah Gadresarah_gadre@med.unc.edu
984-215-5425
Government Study Link:
NCT04243941 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468